Selective targeting of cancer cells using synthetic peptides
- 1 December 2003
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 6 (6) , 363-371
- https://doi.org/10.1016/j.drup.2003.11.002
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- The interface between ErbB and non-ErbB receptors in tumor invasion: clinical implications and opportunities for target discoveryDrug Resistance Updates, 2003
- Synthetic Smac/DIABLO Peptides Enhance the Effects of Chemotherapeutic Agents by Binding XIAP and cIAP1 in SituJournal of Biological Chemistry, 2002
- Converting a Peptide into a Drug: Strategies to Improve Stability and BioavailabilityCurrent Medicinal Chemistry, 2002
- Molecular mechanisms of lymphangiogenesis in health and diseaseCancer Cell, 2002
- Targeting the prostate for destruction through a vascular addressProceedings of the National Academy of Sciences, 2002
- Steps toward mapping the human vasculature by phage displayNature Medicine, 2002
- Therapeutic cancer targeting peptidesPeptide Science, 2002
- Suppression of tumor growth by novel peptides homing to tumor‐derived new blood vesselsFEBS Letters, 2001
- Towards a novel classification of human malignancies based on gene expression patternsThe Journal of Pathology, 2001
- Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse ModelScience, 1998